Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @NCIDirector
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @NCIDirector
-
Another successful
@theNCI Town Hall! I say this frequently, but I can’t stress it enough: I feel like I have the best job in the federal government. I’m grateful to lead such a dedicated and talented group.#CancerWorkforce#NCIFuturepic.twitter.com/Eq2LnsWeeN
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congrats to Drs. Steeg, Thiele, and Shah for their tenure as
@NIH Women Scientist Advisors. Proud of the work they do for@theNCI@NCIResearchCtr, especially their commitment to mentorship.#WomeninSTEM is a key part of our focus on supporting the#CancerWorkforce.https://twitter.com/Tsarmstrong01/status/1221865944940797953 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ned Sharpless, MD proslijedio/la je Tweet
The steep bump in incidence of
#colorectalcancer between 49 & 50 years suggesting an undiagnosed cohort of established cancer that exists in the >50Y pre-colonoscopy period. Note that@AmericanCancer recommends colonoscopy begin at 45y.@JAMANetworkOpen https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2759846 …pic.twitter.com/3X73ERdFSC
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ned Sharpless, MD proslijedio/la je Tweet
Newly Activated
#NCTN#Lungcancer Trial: (S1900C) Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation, a Sub-Study of@LungMAP, led by@SWOG Learn more: https://buff.ly/2vuRHpq pic.twitter.com/uxlw47O4N8
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We encourage more women-owned small businesses to apply for
@NCISbir’s#SBIR#STTR funding. Our team is always here to help#DiversifySBIR.pic.twitter.com/ROCMyTs2yrPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
While there is still more work to be done, these efforts are starting to pay off, leading to a sizable increase in the number of new awards to women.
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
We take this issue seriously at
@theNCI. Last year, we convened a working group to provide strategic recommendations, which led to the development of the@NCISbir Applicant Assistance Program. https://sbir.cancer.gov/aapPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Diversity fosters innovation. By supporting small businesses founded by women, we can enable new technologies that help cancer patients.
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
As this
@washingtonpost story by@Carolynyjohnson shows, women face challenges in biotech. NCI can help address this through@NCISbir’s#SBIR#STTR programs for small businesses.https://www.washingtonpost.com/science/2020/01/29/bias-biotech-funding-has-blocked-women-led-companies/ …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
I say this often, but it’s worth repeating: it really is a special time for cancer research and cancer progress. We’re seeing more and more evidence of that progress, including today’s report from
@CDCgov as reported by@JoelAchenbach of@washingtonposthttps://www.washingtonpost.com/health/us-life-expectancy-ticks-up-as-drug-fatalities-and-cancer-deaths-drop/2020/01/29/2f663376-4206-11ea-b5fc-eefa848cde99_story.html …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ned Sharpless, MD proslijedio/la je Tweet
New
@CDCgov report shows life expectancy in the U.S.
in 2018 for the first time in four years! We're now on the right trajectory to longevity for all Americans. #livelonger Read the@NCHStats report to learn more: http://www.cdc.gov/nchs/products/databriefs/db355.htm …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
FDA v CA Stem Cell clinics is headed to court. Outside of the context of a clinical trial, patients with cancer should avoid risky, unproven therapies. Column: U.S. judge rejects FDA bid to shut down stem cell clinics, dealing blow to regulatorshttps://www.latimes.com/business/story/2020-01-28/judge-fda-stem-cell-clinics …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ned Sharpless, MD proslijedio/la je Tweet
African Americans suffer from lung cancer more than any other population in the U.S., according to
@LungAssociation We applaud our partners at@CancerResrch for partnering with@blkwomenshealth and@SU2C for addressing this critical group. Cancer trials are for everyone.#lcsmhttps://twitter.com/CancerResrch/status/1222188866393735173 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
With this testing, patients and their care teams will have more opportunities to personalize cancer care and potentially improve outcomes. https://www.cms.gov/newsroom/press-releases/cms-expands-coverage-next-generation-sequencing-diagnostic-tool-patients-breast-and-ovarian-cancer …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Pleased with
@CMS’s decision to expand coverage of genetic testing for hereditary breast and ovarian cancer. This is an important step forward in supporting women’s health.Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ned Sharpless, MD proslijedio/la je Tweet
It's never too late to quit smoking. Learn more about my new report with the latest data & science on the health benefits of smoking cessation: https://www.hhs.gov/surgeongeneral/reports-and-publications/tobacco/index.html …
#CessationSGRpic.twitter.com/J5xmrdXqmr
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ned Sharpless, MD proslijedio/la je Tweet
Are you new to NCI
#SBIR#STTR? Sign up for email updates to get the latest news on funding opportunities and program resources geared toward supporting your#CancerTech commercialization journey: https://go.usa.gov/xmDMG pic.twitter.com/Z3PfEnjG41
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ned Sharpless, MD proslijedio/la je Tweet
Join
@realrickpazdur and keynote speaker@NCIDirector for#FDAOncology's birthday recognition and public meeting on Feb. 5 at FDA or online to discuss the future of oncology drug development#OCEProject2025https://go.usa.gov/xdxBBPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ned Sharpless, MD proslijedio/la je Tweet
#NCIGDC data release 22 is now available! Includes new Clinical Proteomic Tumor Analysis Consortium (#CPTAC) project data from the Glioblastoma Multiforme Discovery Study and CPTAC-3 miRNA sequencing data. Find out more: https://go.usa.gov/xdrur pic.twitter.com/lYazvuX6fz
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.